Technical Analysis

Jubilant Life Sciences (₹784.5): Buy

Gurumurthy K BL Research Bureau | Updated on February 28, 2019 Published on March 01, 2019

The outlook for the stock of Jubilant Life Sciences is bullish. The stock rose over 2 per cent on Thursday breaking above a key resistance level of ₹770. This resistance level has been capping the upside since December 2018. The level of ₹770 will now act as a good support for the stock. Intermediate dips to this support level are likely to find fresh buyers coming into the market. A rally to ₹825 is likely in the coming days. Inability to breach ₹825 can trigger a corrective fall to ₹780 or even lower levels. But a strong break above ₹825 will increase the likelihood of the upmove extending to ₹875 and ₹900 levels over the medium-term.

Traders can go long at current levels and also accumulate on dips at ₹775. Stop-loss can be placed at ₹755 for the target of ₹845. Revise the stop-loss higher to ₹805 as soon as the stock moves up to ₹815. The bullish outlook will get negated only if the stock declines decisively below ₹770 again. The next targets are ₹735 and ₹715. However, such a strong fall breaking below ₹770 looks unlikely at the moment.

(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)

c:set var="prUrl" value="" />

Read further by subscribing to

The Hindu Businessline

What You'll Get

  • Web + Mobile

    Access exclusive content of the Hindu Businessline across desktops, tablet and mobile device.

  • Exclusive portfolio stories and investment advice

    Gain exclusive market insights from the Hindu Businessline's research desk.

  • Ad free experience

    Experience cleaner site with zero ads and faster load times.

  • Personalised dashboard

    Customize your preference and get a personalized recommendation of stories based on your intrest.

This article is closed for comments.
Please Email the Editor